Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review
Adverse drug events (ADEs) represent one of the most prevalent types of health-care-related harm, and there is substantial room for improvement in the way that they are currently predicted and detected. We conducted a scoping review to identify key use cases in which artificial intelligence (AI) cou...
Gespeichert in:
| Veröffentlicht in: | The Lancet. Digital health Jg. 4; H. 2; S. e137 - e148 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
Elsevier Ltd
01.02.2022
Elsevier |
| Schlagworte: | |
| ISSN: | 2589-7500, 2589-7500 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!